Chetan Mudrabettu

Physician, Nephrologist, PGI Chandigarh Alumnus

[Vivekanand Jha | विवेकानन्द झा @vjha126]

Read full text https://t.co/QN2pBd6gvS

[Vivekanand Jha | विवेकानन्द झा @vjha126]

➡️ Standard kidney function equations (eGFR) often overestimate renal health for the Indian population.
➡️A landmark study of 1,174 Indian adults shows that global models like CKD-EPI 2021 dont account for lower average muscle mass and unique dietary habits found in India

[Chetan Mudrabettu @chetanmudrabett]

@drrbalu Congratulations Sir!!!
Eagerly waiting to read this!!
The Charioteer is a vivid imagery that features even in the hymn written by Gurudev Tagore, which I love, who's first stanza is our national anthem..

[Manjunath Kulkarni 🇮🇳 @drmjkulkarni]

If Yellapragada Subbarow is unsung in Oncology, so is Sakharam Dhundiraj Mahurkar in Nephrology. Read about him here @hswapnil @arvindcanchi @Nephropoise @vskeskar
https://t.co/Gmaz3JzcJU

[venky @fearingforties]

https://t.co/mUIlZrc0Wk
Submit your abstract and showcase it in the premier Interventional Nephrology conference of the country!
#avatar2026 @VinBhargava @BeheraVineet @Sandyrvsdav @AVATAROrg @ASDINNews
@Jithukurian6 @arvindcanchi @chetanmudrabett @srikanthnephro

[Sandhya Suresh @Sandyrvsdav]

🚨Early Bird Regn!🚨

Join us at AVATAR 2026 3rd Annual Conference of the Association of Vascular Access & Interventional Renal Physicians of India.

📅21-23 Aug
📍Chennai

3 days of cutting-edge discussions on Interventional nephrology
https://t.co/ADnWb0RTUw

#AVATAR2026

[Steven Strogatz @stevenstrogatz]

If you like podcasts about math and science, I hope you'll check out The Joy of Why, which I cohost with my pal @JannaLevin. Our first guest is the wonderful Jennifer Doudna, who discusses RNA, the CRISPR gene-editing mechanism, and her rebellious streak. https://t.co/ssunHBxibr

[NEJM @NEJM]

Original Article: Sodium Bicarbonate for Critically Ill Adults with Metabolic Acidosis and Shock (SODa-BIC trial) https://t.co/uTtuin6rig

#CCR26 | @CritCareReviews

[venky @fearingforties]

https://t.co/YZMrqfqUBQ
submit your abstracts and get your work showcased in India's premier Interventional Nephrology platform #AVATAR2026 @Sandyrvsdav @VinBhargava @arvindcanchi @AVATAROrg @Nair_Sanj @BeheraVineet @InformNephro

[Chetan Mudrabettu @chetanmudrabett]

Very interesting!!! But proving the diagnosis of GI Beriberi is tricky given the nonspecific symptoms and variety of differentials in CKD patients.
Reversal of symptoms with high dose Thiamine is probably the most cost effective way!!

[Robert Centor MD MACP 🇮🇱 @medrants]

Gastrointestinal Beriberi Secondary to Intermittent Hemodialysis With Rapid Improvement Following Thiamine Administration - Day - 2026 - Case Reports in Gastrointestinal Medicine - Wiley Online Library https://t.co/o0uAJtp29l

Fascinating case that taught us much

[Rory Spiegel @EMNerd_]

SODa-BIC just dropped in NEJM. The large, rigorous RCT examining the use of sodium bicarbonate ICU patients with shock and acidosis.

https://t.co/oil4MPDsDU

[Dr Rajeevalochana @Rajeevalochan11]

Happy to share our recent publication in the Indian Journal of Nephrology on Onconephrology in India. Looking forward to discussions and collaborations.https://t.co/YrIxs0laTi
@gudnephron @drshyambansal @isn_india @indianjnephrol @ISNkidneycare @ChennaiKidney

[venky @fearingforties]

https://t.co/gUyfCm7J13 hurry up.. grab your seat and learn from the masters..#avatar2026 #Avfcreationworkshop

[Daniel Coyne @DrDanMO]

Dialyzable β-blockers (higher removal by hemodialysis)
• Atenolol
• Bisoprolol
• Metoprolol
Nondialyzable β-blockers (lower removal by hemodialysis)
• Carvedilol
• Labetalol

[Circulation @CircAHA]

2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome
https://t.co/0POS80XBM2

[Kenar Jhaveri @kdjhaveri]

Obinutuzumab or Tacrolimus in Primary Membranous Nephropathy | New England Journal of Medicine https://t.co/Cb4zRcsYM3

[ERA - European Renal Association @ERAkidney]

5/ #ERA26
📍Conclusions

✍️Signing off, on behalf of #ERA26 social media team @CristinaDeReins

[ERA - European Renal Association @ERAkidney]

⏩ Last presentation from #ERA26 LBCT1 session

🎙️@IgAN_JBarratt presenting: Iptacopan achieves near-normal kidney function decline in prespecified IgA nephropathy (IgAN) patient subgroups: APPLAUSE-IgAN final data

🌐Despite current standard of care, up to 50% of patients with IgAN progress to kidney fallure within 10-20 years from diagnosis

🎯 Ideally, to achieve remission we need to achieve proteinuria less than 0.5, or 0. Complement inhibitors might help achieving this, in this case iptacopan (anti factor B man, blocking alternative pathway)

[Chetan Mudrabettu @chetanmudrabett]

What Prof. Gopalakrishnan has achieved in TamilNadu is something inspirational.
@SOTTO_Karnataka can take valuable lessons from @TRANSTAN_TN

[Arvind Canchi (Conjeevaram)🇮🇳 @arvindcanchi]

Building a Sustainable
Deceased Donation
Ecosystem: The Tamil Nadu
Experience. Editorial by @ngkngkindia and Dr Ethirajan on the steps taken for the sustained and increasing success of DDTx in Tamil Nadu.

[Arvind Canchi (Conjeevaram)🇮🇳 @arvindcanchi]

Building a Sustainable
Deceased Donation
Ecosystem: The Tamil Nadu
Experience. Editorial by @ngkngkindia and Dr Ethirajan on the steps taken for the sustained and increasing success of DDTx in Tamil Nadu.